7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Wang Y et al. | LC, a novel estrone-rhein hybrid compound, concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production by human osteoblastic cells. | 2011 | Mol. Cell. Endocrinol. | pmid:21291955 |
Szulc P et al. | Cortical bone status is associated with serum osteoprotegerin concentration in men: the STRAMBO study. | 2011 | J. Clin. Endocrinol. Metab. | pmid:21565793 |
Zhang M et al. | EP1(-/-) mice have enhanced osteoblast differentiation and accelerated fracture repair. | 2011 | J. Bone Miner. Res. | pmid:20939055 |
Millard SM et al. | Blockade of receptor-activated G(i) signaling in osteoblasts in vivo leads to site-specific increases in cortical and cancellous bone formation. | 2011 | J. Bone Miner. Res. | pmid:20939063 |
Zhang Y et al. | Enhanced osteoclastic resorption and responsiveness to mechanical load in gap junction deficient bone. | 2011 | PLoS ONE | pmid:21897843 |
Tanaka H et al. | Expression of RANKL/OPG during bone remodeling in vivo. | 2011 | Biochem. Biophys. Res. Commun. | pmid:21771583 |
Meulman T et al. | Impact of Porphyromonas gingivalis inoculation on ligature-induced alveolar bone loss. A pilot study in rats. | 2011 | J. Periodont. Res. | pmid:21726226 |
Yang L et al. | Osteoprotegerin and osteoprotegerin ligand expression during human marrow stromal cell differentiation and their effect on osteoclast formation. | 2011 | Chin. Med. J. | pmid:22088466 |
Reinhard H et al. | Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria. | 2011 | Cardiovasc Diabetol | pmid:21801376 |
Jabbar S et al. | Plasma vitamin D and cytokines in periodontal disease and postmenopausal osteoporosis. | 2011 | J. Periodont. Res. | pmid:20731767 |
Curl L and Sampson W | The presence of TNF-alpha and TNFR1 in aseptic root resorption. A preliminary study. | 2011 | Aust Orthod J | pmid:22372265 |
Sheng L et al. | [Inhibitory acting mechanism of psoralen-osthole on bone metastasis of breast cancer--an expatiation viewing from OPG/RANKL/RANK system]. | 2011 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:21812275 |
Yang XY et al. | [Influence of surface modification of titanium on OPG/RANKL mRNA expression in MG-63 human osteoblast-like cells]. | 2011 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:21868322 |
Malliga DE et al. | The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a review. | 2011 | Wien Med Wochenschr | pmid:21870142 |
Guo HL et al. | [Experimental study on the mechanism of icariin improving human osteoblasts proliferation and the expression of OPG protein]. | 2011 | Zhongguo Gu Shang | pmid:21870401 |
McGrath EE | OPG/RANKL/RANK pathway as a therapeutic target in cancer. | 2011 | J Thorac Oncol | pmid:21849854 |
Findlay DM and Atkins GJ | Relationship between serum RANKL and RANKL in bone. | 2011 | Osteoporos Int | pmid:21850548 |
Harada S and Takahashi N | [Control of bone resorption by RANKL-RANK system]. | 2011 | Clin Calcium | pmid:21814016 |
Nakamura M and Udagawa N | [Osteoporosis and RANKL signal]. | 2011 | Clin Calcium | pmid:21814019 |
Christoforidis A et al. | Comparative study of dual energy X-ray absorptiometry and quantitative ultrasonography with the use of biochemical markers of bone turnover in boys with haemophilia. | 2011 | Haemophilia | pmid:20825502 |
Lommi JI et al. | High-density lipoproteins (HDL) are present in stenotic aortic valves and may interfere with the mechanisms of valvular calcification. | 2011 | Atherosclerosis | pmid:21917259 |
Embree M et al. | Role of subchondral bone during early-stage experimental TMJ osteoarthritis. | 2011 | J. Dent. Res. | pmid:21917603 |
Hope S et al. | Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia. | 2011 | J Psychiatr Res | pmid:21889167 |
Shin M et al. | The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. | 2011 | Carcinogenesis | pmid:21890459 |
Grigoropoulou P et al. | The role of the osteoprotegerin/RANKL/RANK system in diabetic vascular disease. | 2011 | Curr. Med. Chem. | pmid:21919846 |
Riancho JA and Delgado-Calle J | [Osteoblast-osteoclast interaction mechanisms]. | 2011 | Reumatol Clin | pmid:21924211 |
Peng S et al. | The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin. | 2011 | Bone | pmid:21925296 |
Fan R et al. | Receptor activator of nuclear factor kappa B ligand and osteoprotegerin expression in chronic apical periodontitis: possible association with inflammatory cells. | 2011 | Chin. Med. J. | pmid:21933620 |
Osorio A et al. | Mineral-bone metabolism markers in young hemodialysis patients. | 2011 | Clin. Biochem. | pmid:21933667 |
Witasp A et al. | Expression of osteoprotegerin in human fat tissue; implications for chronic kidney disease. | 2011 | Eur. J. Clin. Invest. | pmid:21128937 |
Khoshniat S et al. | Phosphate-dependent stimulation of MGP and OPN expression in osteoblasts via the ERK1/2 pathway is modulated by calcium. | 2011 | Bone | pmid:21147284 |
Nybo M et al. | Rosiglitazone decreases plasma levels of osteoprotegerin in a randomized clinical trial with type 2 diabetes patients. | 2011 | Basic Clin. Pharmacol. Toxicol. | pmid:21726411 |
Durual S et al. | Titanium nitride oxide coating on rough titanium stimulates the proliferation of human primary osteoblasts. | 2011 | Clin Oral Implants Res | pmid:21087318 |
Fradet A et al. | Dual function of ERRα in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin. | 2011 | Cancer Res. | pmid:21734015 |
Ashley DT et al. | Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects. | 2011 | Metab. Clin. Exp. | pmid:21087777 |
Campbell GM et al. | Bone quality is partially recovered after the discontinuation of RANKL administration in rats by increased bone mass on existing trabeculae: an in vivo micro-CT study. | 2011 | Osteoporos Int | pmid:20480144 |
Tekkesin MS et al. | The role of RANK/RANKL/OPG signalling pathways in osteoclastogenesis in odontogenic keratocysts, radicular cysts, and ameloblastomas. | 2011 | Head Neck Pathol | pmid:21643971 |
Jiang JQ et al. | Serum osteoprotegerin measurement for early diagnosis of chronic kidney disease-mineral and bone disorder. | 2011 | Nephrology (Carlton) | pmid:21649792 |
Choi EM | Honokiol isolated from Magnolia officinalis stimulates osteoblast function and inhibits the release of bone-resorbing mediators. | 2011 | Int. Immunopharmacol. | pmid:21621646 |
Ueland T et al. | Osteoprotegerin levels predict mortality in patients with symptomatic aortic stenosis. | 2011 | J. Intern. Med. | pmid:21623962 |
Wheater G et al. | Suppression of bone turnover by B-cell depletion in patients with rheumatoid arthritis. | 2011 | Osteoporos Int | pmid:21625887 |
Karadag-Saygi E et al. | The effect of risedronate treatment on serum osteoprotegerin and bone marker levels in postmenopausal women with osteoporosis. | 2011 | Gynecol. Endocrinol. | pmid:21627558 |
Taylor R et al. | Osteoclast formation and function in pigmented villonodular synovitis. | 2011 | J. Pathol. | pmid:21706481 |
Conaway HH et al. | Retinoids stimulate periosteal bone resorption by enhancing the protein RANKL, a response inhibited by monomeric glucocorticoid receptor. | 2011 | J. Biol. Chem. | pmid:21715325 |
Colombini A et al. | Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing. | 2011 | Int Orthop | pmid:20623281 |
Kanayama K et al. | Osteoclast and osteoblast activities on carbonate apatite plates in cell cultures. | 2011 | J Biomater Appl | pmid:20624844 |
Baloul SS et al. | Mechanism of action and morphologic changes in the alveolar bone in response to selective alveolar decortication-facilitated tooth movement. | 2011 | Am J Orthod Dentofacial Orthop | pmid:21435543 |
Wang AY | Consequences of chronic inflammation in peritoneal dialysis. | 2011 | Semin. Nephrol. | pmid:21439430 |
Ikeda K et al. | Conditional expression of constitutively active estrogen receptor α in osteoblasts increases bone mineral density in mice. | 2011 | FEBS Lett. | pmid:21439958 |
Teramachi J et al. | Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis. | 2011 | Lab. Invest. | pmid:21339747 |
Katz J et al. | Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw. | 2011 | Int J Oral Maxillofac Surg | pmid:21396799 |
Bitto A et al. | Genistein aglycone effect on bone loss is not enhanced by supplemental calcium and vitamin D3: a dose ranging experimental study. | 2011 | Phytomedicine | pmid:21397481 |
Di Bartolo BA et al. | Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcification. | 2011 | Cardiovasc. Res. | pmid:21447702 |
Ho TY et al. | Effects of relaxin and estrogens on bone remodeling markers, receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), in rat adjuvant-induced arthritis. | 2011 | Bone | pmid:21419242 |
Chasseraud M et al. | Tumor necrosis factor-related apoptosis-inducing ligand and vascular calcification. | 2011 | Ther Apher Dial | pmid:21426505 |
Duheron V et al. | Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit. | 2011 | Proc. Natl. Acad. Sci. U.S.A. | pmid:21402940 |
Vidal C et al. | Functional polymorphisms within the TNFRSF11B (osteoprotegerin) gene increase the risk for low bone mineral density. | 2011 | J. Mol. Endocrinol. | pmid:21994215 |
Hemingway F et al. | In vitro generation of mature human osteoclasts. | 2011 | Calcif. Tissue Int. | pmid:21960377 |
Dimitriadis K et al. | Exercise blood pressure response is related to asymmetric dimethylarginine and osteoprotegerin in hypertension. | 2011 | Int. J. Cardiol. | pmid:21975354 |
Yao Y et al. | Synergistic enhancement of new bone formation by recombinant human bone morphogenetic protein-2 and osteoprotegerin in trans-sutural distraction osteogenesis: a pilot study in dogs. | 2011 | J. Oral Maxillofac. Surg. | pmid:22018252 |
Brown TT et al. | Bone turnover, osteoprotegerin/RANKL and inflammation with antiretroviral initiation: tenofovir versus non-tenofovir regimens. | 2011 | Antivir. Ther. (Lond.) | pmid:22024522 |
Hsieh TP et al. | Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis. | 2011 | Phytomedicine | pmid:20554188 |
Yener S et al. | Is there an association between non-functioning adrenal adenoma and endothelial dysfunction? | 2011 | J. Endocrinol. Invest. | pmid:20530985 |
de Souza JA et al. | Expression of suppressor of cytokine signaling 1 and 3 in ligature-induced periodontitis in rats. | 2011 | Arch. Oral Biol. | pmid:21511249 |
Claro T et al. | Staphylococcus aureus protein A binds to osteoblasts and triggers signals that weaken bone in osteomyelitis. | 2011 | PLoS ONE | pmid:21525984 |
Giro G et al. | Influence of estrogen deficiency on bone around osseointegrated dental implants: an experimental study in the rat jaw model. | 2011 | J. Oral Maxillofac. Surg. | pmid:21530046 |
Won KY et al. | RANK signalling in bone lesions with osteoclast-like giant cells. | 2011 | Pathology | pmid:21532526 |
Naot D et al. | Molecular mechanisms involved in the mitogenic effect of lactoferrin in osteoblasts. | 2011 | Bone | pmid:21515435 |
Aydin H et al. | Effect of oxidative stress on aorta and tibia osteoprotegerin gene expression in ovariectomized rats. | 2011 | Minerva Endocrinol. | pmid:21519319 |
Altinova AE et al. | Relationship between serum osteoprotegerin, glycemic control, renal function and markers of atherosclerosis in type 2 diabetes. | 2011 | Scand. J. Clin. Lab. Invest. | pmid:21486111 |
Mercatali L et al. | Bone metastases detection by circulating biomarkers: OPG and RANK-L. | 2011 | Int. J. Oncol. | pmid:21491082 |
Stein SH et al. | Statins regulate interleukin-1β-induced RANKL and osteoprotegerin production by human gingival fibroblasts. | 2011 | J. Periodont. Res. | pmid:21463327 |
Huang CH et al. | Osteoprotegerin genetic polymorphisms and age of symptom onset in ankylosing spondylitis. | 2011 | Rheumatology (Oxford) | pmid:20974615 |
Pepene CE et al. | Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction. | 2011 | Eur. J. Endocrinol. | pmid:20974706 |
Dimitri P et al. | Adipokines, bone-derived factors and bone turnover in obese children; evidence for altered fat-bone signalling resulting in reduced bone mass. | 2011 | Bone | pmid:20932948 |
Sipos W et al. | OPG-Fc treatment in growing pigs leads to rapid reductions in bone resorption markers, serum calcium, and bone formation markers. | 2011 | Horm. Metab. Res. | pmid:22161252 |
Akinci B et al. | Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome. | 2011 | Diabetes Res. Clin. Pract. | pmid:20970873 |
Toffoli B et al. | Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. | 2011 | Mol. Cell. Endocrinol. | pmid:20832449 |
Rauch A et al. | An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation. | 2011 | FASEB J. | pmid:21233489 |
Ueland T et al. | Osteoprotegerin predicts progression of chronic heart failure: results from CORONA. | 2011 | Circ Heart Fail | pmid:21216833 |
Tang T et al. | Effect of water-soluble P-chitosan and S-chitosan on human primary osteoblasts and giant cell tumor of bone stromal cells. | 2011 | Biomed Mater | pmid:21205994 |
Attia EA et al. | Assessment of osteoporosis in psoriasis with and without arthritis: correlation with disease severity. | 2011 | Int. J. Dermatol. | pmid:21182499 |
Sun Z and Tee BC | Molecular variations related to the regional differences in periosteal growth at the mandibular ramus. | 2011 | Anat Rec (Hoboken) | pmid:21157918 |
Cannon JG et al. | Follicle-stimulating hormone promotes RANK expression on human monocytes. | 2011 | Cytokine | pmid:21159522 |
Choe JY et al. | Radiographic bone damage in chronic gout is negatively associated with the inflammatory cytokines soluble interleukin 6 receptor and osteoprotegerin. | 2011 | J. Rheumatol. | pmid:21159831 |
Mahoney DJ et al. | TSG-6 inhibits osteoclast activity via an autocrine mechanism and is functionally synergistic with osteoprotegerin. | 2011 | Arthritis Rheum. | pmid:21162099 |
Preshaw PM and Taylor JJ | How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? | 2011 | J. Clin. Periodontol. | pmid:21323705 |
Basu R et al. | Effects of physiological variations in circulating insulin levels on bone turnover in humans. | 2011 | J. Clin. Endocrinol. Metab. | pmid:21325461 |
Kamiya N et al. | Significance of serum osteoprotegerin and receptor activator of nuclear factor κB ligand in Japanese prostate cancer patients with bone metastasis. | 2011 | Int. J. Clin. Oncol. | pmid:21327451 |
Eslami B et al. | Reduced osteoclastogenesis and RANKL expression in marrow from women taking alendronate. | 2011 | Calcif. Tissue Int. | pmid:21327765 |
Jørgensen L et al. | Serum osteoprotegerin levels are related to height loss: the Tromsø Study. | 2011 | Eur. J. Epidemiol. | pmid:21331661 |
Yuan H et al. | Receptor activator of nuclear factor kappa B ligand antagonists inhibit tissue inflammation and bone loss in experimental periodontitis. | 2011 | J. Clin. Periodontol. | pmid:22092474 |
Feng Z et al. | An oligodeoxynucleotide with promising modulation activity for the proliferation and activation of osteoblast. | 2011 | Int J Mol Sci | pmid:21731457 |
Mai QG et al. | Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. | 2011 | J. Cell. Biochem. | pmid:21618594 |
Garcia VG et al. | Treatment of experimental periodontal disease with antimicrobial photodynamic therapy in nicotine-modified rats. | 2011 | J. Clin. Periodontol. | pmid:22092666 |
Kornak U | Animal models with pathological mineralization phenotypes. | 2011 | Joint Bone Spine | pmid:21550285 |
Santini D et al. | Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients. | 2011 | PLoS ONE | pmid:21559440 |
Hen K et al. | [Osteoprotegerin--a new atherosclerosis marker]. | 2011 | Pol. Merkur. Lekarski | pmid:22097184 |
Mariúba MV et al. | Effect of triiodothyronine on the maxilla and masseter muscles of the rat stomatognathic system. | 2011 | Braz. J. Med. Biol. Res. | pmid:21584440 |
Tang Y et al. | Porphyromonas endodontalis lipopolysaccharides induce RANKL by mouse osteoblast in a way different from that of Escherichia coli lipopolysaccharide. | 2011 | J Endod | pmid:22099899 |